Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register

Internal Medicine Journal

Volumn 42, Issue 11, 2012, Pages 1207-1212

  Richardson, A K ^a   Clarke, G ^b   Sabel, C E ^d   Pearson, J F ^b   Mason, D F ^c   Taylor, B V ^e  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF EXETER   (United Kingdom)

^e UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Confidentiality; Data collection; Epidemiologic method; Population; Prevalence

Indexed keywords

ARTICLE; BIRTH; CONFIDENTIALITY; DATA BASE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; NEW ZEALAND; ORGANIZATION AND MANAGEMENT; PATIENT IDENTIFICATION; PATIENT PARTICIPATION; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; PRIVACY; REGISTER; SEX;

CONFIDENTIALITY; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; HEALTH SURVEYS; HUMANS; MEDICAL RECORDS; MULTIPLE SCLEROSIS; NEW ZEALAND; PATIENT IDENTIFICATION SYSTEMS; PREVALENCE; PRIVACY; QUESTIONNAIRES;

EID: 84869771465     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2012.02754.x     Document Type: Article

References (11)

1. Taylor BV, Pearson JF, Clarke G, Mason D, Abernethy D, Willoughby E etal. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler 2010; 16: 1422-1431.
2. Skegg DCG, Corwin PA, Craven RS, Malloch JA, Pollock M. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987; 50: 134-139.
3. Chancellor AM, Addidle M, Dawson K. Multiple sclerosis is more prevalent in northern New Zealand than previously reported. Intern Med J 2003; 33: 79-83.
4. New Zealand Government. New Zealand Privacy Act 1993 and Amending Legislation. 2012. [cited 2012 Mar 12]. Available from URL: http://www.legislation.govt.nz/act/public/1993/0028/latest/DLM296639.html
5. Privacy Commissioner. New Zealand Health Information Privacy Code 1994. 2012. [cited 2012 Mar 12]. Available from URL: http://privacy.org.nz/health-information-privacy-code/
6. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD etal. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
7. McGuigan C, McCarthy A, Quigley C, Bannan L, Hawkins S, Hutchinson M. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. J Neurol Neurosurg Psychiatry 2004; 75: 572-576.
8. Fox CM, Bensa S, Bray I, Zajicek JP. The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria. J Neurol Neurosurg Psychiatry 2004; 75: 56-60.
9. Koepsell TD, Weiss NS. Epidemiologic Methods. New York: Oxford University Press; 2003.
10. Hook EB, Regal RR. The value of capture-recapture methods even for apparently exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol 1992; 135: 1060-1067.
11. AIDS Epidemiology Group. HIV and AIDS Surveillance in New Zealand: Guide for Clinicians. Dunedin: University of Otago; 1989. [cited 2012 Mar 12]. Available from URL: http://dnmeds.otago.ac.nz/departments/psm/research/aids/pdf/Guide%20for%20clinicians.pdf